Introduction
============

Transition-metal-catalyzed C--H functionalization is an important and efficient synthetic tool in organic synthesis owing to its straightforward and economical features.[@cit1]--[@cit6] Although directing-group-oriented aryl C--H functionalization has developed rapidly in the past decade, some limitations have remained difficult to overcome.[@cit7]--[@cit9] For example, C--H activation often selectively occurs at the *ortho* position relative to the directing group.[@cit10]--[@cit12] However, when two or more directing groups coexist in one molecule, C--H activation directed by weakly coordinating groups is difficult to achieve owing to competing strongly coordinating directing groups, such as N-heterocycles.[@cit13]--[@cit21] These groups often preferentially bind with transition metals and interfere with C--H functionalization through the desired directing group, which hinders late-stage modification in drug discovery.[@cit22]--[@cit24] Recently, Dai, Yu, and Ackermann *et al.* reported pioneering examples of palladium-,[@cit25] copper-,[@cit26] and cobalt-catalyzed[@cit27] site-selective C--H functionalizations of amides and imidates that tolerated strongly coordinating N-heterocycles ([Fig. 1A--C](#fig1){ref-type="fig"}). However, switching the C--H functionalization selectivity of substrates containing two directing groups remains challenging ([Fig. 1D](#fig1){ref-type="fig"}).[@cit28]--[@cit38]

![Overcoming the limitation of directed C--H functionalization.](c9sc03691a-f1){#fig1}

Both N-heterocycles and sulfonamides are ubiquitous in biologically active molecules owing to their hydrogen bond forming abilities and favorable drug-like properties.[@cit39]--[@cit43] Considering their dual pharmacological effects, switching the selectivity of the C--H functionalization of aryl sulfonamides containing strongly coordinating N-heterocycles would be invaluable in the late-stage modification of potential drug molecules ([Fig. 2A](#fig2){ref-type="fig"}).[@cit44]--[@cit46] In this study, we successfully switched the selectivity of the C--H carbenoid functionalization[@cit47]--[@cit66] of sulfonamides[@cit67]--[@cit80] containing N-heterocycles[@cit81] using a rhodium catalyst. The selectivity was precisely controlled by changing the reaction medium polarity and additive concentration, affording C--H activation at the *ortho* position relative to the N-heterocycle (charge-neutral forms, denoted as L-type ligands) or sulfonamide (easily deprotonated to charge-negative forms, denoted as X-type ligands) directing groups.

![Site-selective C--H functionalization of sulfonamides containing N-heterocycles.](c9sc03691a-f2){#fig2}

Results and discussion
======================

Initially, this Rh([iii]{.smallcaps})-catalyzed site-selective C--H carbenoid functionalization was investigated for solvent effects (0.05 M concentration) by using AgOAc as an additive at 60 °C, with the results summarized in [Table 1](#tab1){ref-type="table"} (entries 1 to 5). When 3-methyl-4-thiazole-*N*-acetyl sulfonamide (**1a**) was used as a model substrate, C--H carbenoid functionalization product **3′** at the *ortho*-position of thiazole was only observed and isolated in 79% yield when MeOH (a polar protonic solvent) was used as the reaction solvent ([Table 1](#tab1){ref-type="table"}, entry 1). Other tested polar solvents, such as DMF and MeCN, also favored generation of the C--H activated product at the *ortho*-position of the thiazole group ([Table 1](#tab1){ref-type="table"}, entries 2 and 3). When non-polar solvents were used, such as DCE and toluene, the thiazole-directed C--H activated product was decreased significantly ([Table 1](#tab1){ref-type="table"}, entries 4 and 5). It was notable that the amount of sulfonamide directed C--H activated product **3** was close to thiazole directed C--H activated product **3′** (**3**/**3′** ratio, 1 : 1.6) when less-polar toluene was used as the reaction solvent ([Table 1](#tab1){ref-type="table"}, entry 5). These results suggested that the polarity of the solvent strongly determined the site-selectivity of this rhodium catalyzed C--H carbenoid functionalization: the less polar the solvent, the more favorable was the sulfonamide-directed C--H activation product. Importantly, this phenomenon was more obvious at low concentrations ([Table 1](#tab1){ref-type="table"}, entries 6--8), and when the reaction concentration was reduced to 0.01 M in DCE or toluene, an increasing amount of sulfonamide-directed activation product **3** was observed. It was worth noting that product **3** was isolated as the major product and the **3**/**3′** ratio could reach 33 : 1 when the reaction was carried out in toluene at 0.01 M concentration ([Table 1](#tab1){ref-type="table"}, entry 7). The result given by a solvent mixture of DCE and toluene (v/v = 1 : 1) more clearly reflected the solvent polarity effect on this Rh([iii]{.smallcaps})-catalyzed site-selective C--H carbenoid functionalization ([Table 1](#tab1){ref-type="table"}, entry 8). Further decreasing the concentration to 0.005 M resulted in an excellent site-selectivity of **3** (**3**/**3′** ratio, \>99 : 1, [Table 1](#tab1){ref-type="table"}, entry 9). Reducing the amount of \[RhCp\*Cl~2~\]~2~ to 2.5 mol% resulted in a decreased **3** : **3′** ratio of 28 : 1, which showed that 5 mol% of the catalyst loading amount was necessary for this selective sulfonamide directed C--H carbenoid functionalization (entry 10). In contrast, increasing the reaction concentration led to increase of the thiazole-directed product **3′**, which also well reflected the significant solvent effect of this site-selective C--H carbenoid functionalization ([Table 1](#tab1){ref-type="table"}, entries 11 and 12). On the other hand, the effect of the amount of AgOAc on site-selectivity was also considered and systematically investigated in DCE ([Table 1](#tab1){ref-type="table"}, entries 13 to 16). Increasing the amount of AgOAc resulted in a lower **3**/**3′** ratio (entries 13 and 14), which reached \<1 : 99 when the amount of AgOAc was 8- and 12-fold that of \[RhCp\*Cl~2~\]~2~ respectively. It is worth noting that 2.5 mol% \[RhCp\*Cl~2~\]~2~ and 60 mol% AgOAc loading amount could guarantee an excellent site-selectivity of **3′** (**3**/**3′** ratio, \<1 : 99, entry 15). These results showed that increasing the amount of AgOAc favored C--H functionalization at the thiazole *ortho*-position. It may be possible that changing the AgOAc concentration affected the polarity of the reaction environment, influencing the site-selectivity. It is also possible that AgOAc plays the role of a Lewis acid which could bind to an N-heterocycle or diazo compound and affect the site-selectivity.[@cit82] When a more economic acetate salt tetrabutylammonium acetate was used as an additive instead of AgOAc, similar yields were obtained. However, the site-selectivities of the C--H carbenoid functionalization were significantly reduced (entries 17 and 18). Therefore, two optimal conditions to switch site-selectivity at the *ortho*-position of sulfonamide and N-heterocycle were chosen respectively (entries 9 and 15). These two methods not only gave good yields, but more importantly excellent site-selectivities.

###### Optimization of the site-selective C--H carbenoid functionalization[^*a*^](#tab1fna){ref-type="fn"}

  ![](c9sc03691a-u1.jpg){#ugr1}                                                                                        
  ------------------------------------------ ------------ --------------------- ------------- ------------------------ --------------
  1                                          5/20         MeOH                  0.05 M        **3′**/79                Only **3′**
  2                                          5/20         DMF                   0.05 M        **3′**/77                1 : 48
  3                                          5/20         MeCN                  0.05 M        **3′**/78                1 : 11
  4                                          5/20         DCE                   0.05 M        **3′**/65                1 : 4
  5                                          5/20         Toluene               0.05 M        **3** + **3′**/26 + 50   1 : 1.6
  6                                          5/20         DCE                   0.01 M        **3** + **3′**/40 + 44   1 : 1
  7                                          5/20         Toluene               0.01 M        **3**/80                 33 : 1
  8                                          5/20         Toluene/DCE = 1 : 1   0.01 M        **3**/62                 4 : 1
  **9**                                      **5/20**     **Toluene**           **0.005 M**   ****3**** **/81**        **\>99 : 1**
  10                                         2.5/10       Toluene               0.005 M       **3**/80                 28 : 1
  11                                         5/20         DMF                   0.25 M        **3′**/81                \<1 : 99
  12                                         5/20         MeCN                  0.25 M        **3′**/80                1 : 47
  13                                         5/40         DCE                   0.05 M        **3′**/88                \<1 : 99
  14                                         5/60         DCE                   0.05 M        **3′**/87                \<1 : 99
  **15**                                     **2.5/60**   **DCE**               **0.05 M**    ****3′**** **/88**       **\<1 : 99**
  16                                         2.5/20       DCE                   0.05 M        **3′**/83                1 : 30
  17[^*d*^](#tab1fnd){ref-type="table-fn"}   5/20         Toluene               0.005 M       **3**/79                 26 : 1
  18[^*d*^](#tab1fnd){ref-type="table-fn"}   2.5/60       DCE                   0.05 M        **3** + **3′**/29 + 46   1 : 1.5

^*a*^Reaction conditions: \[RhCp\*Cl~2~\]~2~ (*x* mol%), AgOAc (*y* mol%), **1a** (0.125 mmol), **2a** (1.1 equiv.), solvent, 60 °C.

^*b*^Isolated yield.

^*c*^Determined by ^1^H NMR analysis of the crude reaction mixture before separation.

^*d*^Tetrabutylammonium acetate instead of AgOAc.

With the two optimal conditions in hand, sulfonamide substrates containing various N-heterocycles in a competitive position were further investigated, including thiazole, pyrazole, imidazole, pyridine, pyrimidine, and pyrazine substrates ([Scheme 1](#sch1){ref-type="fig"}). As expected, sulfonamide-group-directed *ortho*-C--H carbenoid functionalization proceeded in the presence of 5.0 mol% \[RhCp\*Cl~2~\]~2~ catalyst and 20 mol% AgOAc as the additive in less-polar toluene (0.005 M) at 60 °C, affording excellent site-selectivity ([Scheme 1A](#sch1){ref-type="fig"}, Method A, **4--14**). In addition to phenyl sulfonamides, thienyl sulfonamides also showed excellent site-selectivity (**15** and **16**), while substrates containing phosphate ester and sulfone ester diazo groups instead of dimethyl 2-diazomalonate also gave satisfactory results (**17** and **18**). Notably, C--H di-activation at the *ortho*-positions relative to the sulfonamide group afforded the major product when *para*-heterocycle-substituted benzenesulfonamide was used (**19--22**). As shown in [Scheme 1B](#sch1){ref-type="fig"}, when the reaction was conducted in DCE (0.05 M), the N-heterocycle-directed C--H carbenoid functionalization of this difunctional compound performed well in the presence of 2.5 mol% \[RhCp\*Cl~2~\]~2~ catalyst and 60 mol% AgOAc as the additive at 60 °C, with good yields and excellent site-selectivity (Method B, **23--30**). A 1,2-disubstituted substrate was also tried, but no desired carbenoid functionalization product was obtained, which may be the result of a bidentate coordination, impeding the free coordination site for cyclometallation.

![Site-selective *ortho* C--H carbenoid functionalization of sulfonamides containing N-heterocycles. (A) Method A: \[RhCp\*Cl~2~\]~2~ (5 mol%), AgOAc (20 mol%), sulfonamides containing N-heterocycles (0.125 mmol), **2a** (1.1 equiv.), toluene (25 mL), 60 °C. brsm = based on the recovered starting material. ^*a*^2.1 equiv. of **2a** was used. (B) Method B: \[RhCp\*Cl~2~\]~2~ (2.5 mol%), AgOAc (60 mol%), sulfonamides containing N-heterocycles (0.125 mmol), **2a** (1.1 equiv.), DCE (2.5 mL), 60 °C.](c9sc03691a-s1){#sch1}

Intermolecular competition experiments were conducted to explore the unique chemoselectivity of difunctional sulfonamides containing N-heterocycle substrates ([Scheme 2](#sch2){ref-type="fig"}). Notably, X-type sulfonamides outcompeted strongly coordinating L-type thiazole, pyrazole, and pyridine substrates using method A. In contrast, when the competition reaction was conducted using method B, N-heterocycle-oriented C--H carbenoid functionalization was the major pathway. These intermolecular competition results implied that changing the C--H carbenoid functionalization reaction conditions could affect the competitive reactivity between X-type and L-type directing groups. More importantly, this strategy could prevent interference from L-type N-heterocycles to afford X-type sulfonamide-oriented C--H activation, despite N-heterocycles possessing strongly coordinating properties with metal catalysts.

![Intermolecular competition experiments between X-type sulfonamides and L-type N-heterocycles.](c9sc03691a-s2){#sch2}

The mechanism of the site-selective aryl C--H carbenoid functionalization between sulfonamide and N-heterocycles was further investigated by experimental studies and theoretical calculations. The mechanism of directing group oriented aryl C--H carbenoid functionalization has been illustrated in the previous literature, and three major steps including C--H activation, metal--carbene formation and final C--C bond formation process were proposed to take place.[@cit50] Firstly, as shown in [Scheme 3](#sch3){ref-type="fig"}, isotope-labelling experiments of 3-methyl-4-thiazole-*N*-acetyl sulfonamide (**1a**) by method A and B in the presence of \[D~4~\]-MeOD showed that reversible processes for sulfonamide and thiazole directed C--H activation were involved under method A and B conditions.[@cit83]--[@cit85] Notably, there was a relatively slight H/D exchange (5%) at the *ortho* position of the thiazole group using \[D~4~\]-MeOD as a co-solvent in the method A catalytic system, implying weak reversible properties. As shown in [Scheme 4](#sch4){ref-type="fig"}, kinetic isotope effect (KIE) experimental results showed a relatively small value, indicating that C--H bond cleavage was likely not the rate-determining step in the catalytic cycle.[@cit86],[@cit87] These results suggested that the selectivity does not appear in the first C--H activation step, but in the subsequent steps possibly.

![Isotope-labelling experiments.](c9sc03691a-s3){#sch3}

![Kinetic isotope effect experiments.](c9sc03691a-s4){#sch4}

In order to delve into our conjecture about the mechanism on selectivity, density functional theory (DFT) calculations were performed. The RhCp\*(OAc)~2~ complex was commonly considered as the active catalyst under the conditions of \[RhCp\*Cl~2~\]~2~ with an abundant AgOAc additive.[@cit51],[@cit54],[@cit57] As implied in our experiments, the results of site-selective C--H carbenoid functionalization catalyzed by RhCp\*(OAc)~2~ were similar to those catalyzed by RhCp\*Cl~2~/AgOAc, which proved that RhCp\*(OAc)~2~ was an active catalyst for the C--H carbenoid functionalization (details in the ESI[†](#fn1){ref-type="fn"}). An easier N--H deprotonation of the acetyl-substituted sulfonamide was predicted, and the active catalyst RhCp\*(OAc)~2~ would firstly dissociate one OAc^--^ ligand to coordinate with the deprotonated sulfonamide substrate to form the reactant complex **RC**. Similar to previous reports, domino C--H activation, metal--carbene formation, and finally C--C bond formation processes were predicted to take place.[@cit88]--[@cit90] The deprotonated sulfonamide moiety or *para*-thiazole group would act as a directing group to locate the Rh([iii]{.smallcaps}) center adjacent to the *ortho*-C--H bond of either the sulfonamide or thiazole group, which guaranteed facilitation of the *ortho*-C--H activation processes in the transition state **TS1** or **TS1′**. Both aryl C--H deprotonation to the mono-coordinated OAc^--^ ligand and Rh--C bond formation processes were observed in the concerted-metalation--deprotonation (CMD)[@cit91]--[@cit93] type C--H activation transition state **TS1** or **TS1′**. Subsequently, the Rh([iii]{.smallcaps})-bound neutral HOAc molecule would be easily replaced by the diazo compound **2a**, and metal--carbene formation through clear nitrogen extrusion processes was observed in both **TS2** and **TS2′**. The active metal--carbene would attack an adjacent aryl carbon center to generate C--C bond formation transition state **TS3** or **TS3′**. Finally, transient product **PC** or **PC′** was obtained through site-selective carbenoid functionalization at the *ortho*-position of either the sulfonamide or thiazole moiety. Alternatively, the active catalyst RhCp\*(OAc)~2~ might directly react with diazo compound **2a** to form a metal--carbene complex *via* a similar nitrogen extrusion process in **TS~carbene~**.

The profiles of the potential energy surface proposed above are shown in [Fig. 3](#fig3){ref-type="fig"}. It can be noted that the energies of the direct metal--carbene formation transition state **TS~carbene~** (31.2 and 34.2 kcal mol^--1^ in toluene and DCE, respectively) were higher than the barriers depicted in [Fig. 3](#fig3){ref-type="fig"}, which reconfirmed the fact that the active Rh([iii]{.smallcaps}) catalysts would preferentially react with aryl substrates (details in the ESI[†](#fn1){ref-type="fn"}). As depicted in [Fig. 3](#fig3){ref-type="fig"}, the free energy barrier in the metal--carbene formation was higher than those of the C--H activation process and C--C formation step. The calculated results demonstrated that the C--H activation step was not rate-determining, which was consistent with experimental KIE results. In addition, stoichiometric C--H rhodation experiments were conducted ([Scheme 5](#sch5){ref-type="fig"}). As shown in [Scheme 5A](#sch5){ref-type="fig"}, 14% and 0% D, respectively, were incorporated at the *ortho*-positions of the sulfonamide and thiazole groups at a lower reaction concentration (0.005 M) in toluene, which was supported by the energy barrier of the *ortho*-sulfonamide C--H activation in toluene (**TS1** is 8.6 kcal mol^--1^ lower than **TS1′**). Furthermore, the competitive C--H activation results shown in [Scheme 5B](#sch5){ref-type="fig"} confirmed the calculated narrow free energy gap between **TS1** and **TS1′** (2.1 kcal mol^--1^) in DCE. The concentration factor was considered in [Scheme 3](#sch3){ref-type="fig"}, which implied that the increased concentration of reaction complexes and more polarized solvent would favour thiazole-directed C--H activation. The experimental observations were in consistence with calculated C--H activation barriers, especially in the pathway of the more polarized solution (*ε* = 25.0) wherein a narrower free energy gap between **TS1** and **TS1′** was observed (1.2 kcal mol^--1^). More importantly, a stable thiazole-directed intermediate **IM′-OAc** was generated, which was responsible for more deuteration at the thiazole side in [Scheme 3B](#sch3){ref-type="fig"}.

![Profile of the potential energy surface (PES) of site-selective carbenoid functionalization in aryl sulfonamide **1a** catalyzed by the RhCp\*(OAc)~2~ complex. The energy of reactant **RC** is referred to as the total energy of dissociative reactants (**1a**, **2a**, RhCp\*(OAc)~2~).](c9sc03691a-f3){#fig3}

![Stoichiometric C--H rhodation experiment.](c9sc03691a-s5){#sch5}

The reaction selectivities were further rationalized. As depicted in [Fig. 3](#fig3){ref-type="fig"}, the sulfonamide-directed pathway was more energetically favourable than the thiazole-directed pathway in toluene (red pathway). The calculated results were in good agreement with the experimental observations that *ortho*-sulfonamide C--H carbenoid functionalization product **3** was the major product in toluene ([Table 1](#tab1){ref-type="table"}, entries 7, 9 and 10). Furthermore, close relative free energy barriers of C--H activation transition states **TS1** (18.8 kcal mol^--1^) and **TS1′** (20.9 kcal mol^--1^), and of metal--carbene formation transition states **TS2** (25.1 kcal mol^--1^) and **TS2′** (25.7 kcal mol^--1^) in DCE were observed (black pathway). The calculated competitive reaction pathways in DCE were in good agreement with experimental findings that both *ortho*-sulfonamide product **3** and *ortho*-thiazole product **3′** were obtained in DCE at a lower AgOAc concentration ([Table 1](#tab1){ref-type="table"}, entry 6). The use of a more polarized solvent and/or high concentration of reaction complexes was also investigated, which together contributed to the increasing polarity of the reaction environment. As described above, the metal--carbene formation process was the rate-determining step, and therefore, the energy alterations of **TS2** and **TS2′** under various polarization conditions were investigated. As depicted in [Fig. 4A](#fig4){ref-type="fig"}, the thiazole-directed **TS2′** was more polarized than the sulfonamide-directed **TS2**, which would rationalize the free energy changes in [Fig. 4B](#fig4){ref-type="fig"} wherein the thiazole-directed **TS2′** was better stabilized in high polarity surroundings. Therefore, PES profiles in a more polarized solution are also provided in [Fig. 3](#fig3){ref-type="fig"} (blue pathway). As demonstrated in [Fig. 3](#fig3){ref-type="fig"}, the energies of the thiazole-directed reaction species were decreased and the free energy of the rate-determining **TS2′** was lower than that of **TS2**. Meanwhile, as mentioned above, the introduction of excess OAc^--^ ligand would result in a more stable thiazole-directed intermediate **IM2′-OAc**. Thereby, the decreased thiazole-directed energy barriers and the important OAc^--^ ligand participation demonstrated in [Fig. 3](#fig3){ref-type="fig"} (blue), as well as the better stabilization of **TS2′** in more polarized surroundings shown in [Fig. 4B](#fig4){ref-type="fig"}, would reasonably explain the reaction selectivities under the conditions of more polarized solvent and/or high concentration of reaction complexes demonstrated in [Table 1](#tab1){ref-type="table"}.

![(A) Electrostatic potential (ESP) and dipole moment of **TS2** and **TS2′** in DCE. (B) Relative energy changes of **TS2** and **TS2′** with increasing solvent dielectric constant. The energy of **TS2** in toluene (*ε* = 2.4) was set to zero.](c9sc03691a-f4){#fig4}

Conclusions
===========

In summary, we have developed a Rh([iii]{.smallcaps})-catalyzed arene C--H carbenoid functionalization with good yields and excellent site-selectivity switching for aryl sulfonamides containing strongly coordinating N-heterocycles. The polarity of the reaction environment was an important factor influencing the site-selectivity. Notably, the combination of a less-polar solvent, such as toluene, and a lower additive concentration favored C--H functionalization at the *ortho*-position relative to the sulfonamide group with excellent site-selectivity. Furthermore, strongly coordinating N-heterocycles, including pyridine, pyrrole, thiazole, pyrimidine, and pyrazine, were tolerated. This switchable site-selectivity carbenoid functionalization methodology is suitable for the late-stage modification of N-heterocycle-derived sulfonamide drugs.
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